GlassScriptPhysician profile
Naiem Nassiri
NPI 1033366745
$348,318.12
in general payments reported to CMS, 2019-2025
23 companies · $12K in 2025
The $12K reported for 2025 was more than what 92% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $25K · 2021: $79K · 2022: $146K · 2023: $35K · 2024: $36K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Travel and Lodging: $9,614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,150.00 |
| Food and Beverage | $12,527.96 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,300.00 |
| Travel and Lodging | $9,614.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $144,161.74 | 2021-2025 | Endurant Iis, Heli-Fx Endoanchor System, Valiant Captivia |
| Bolton Medical INC | $89,369.22 | 2019-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Endologix LLC | $40,872.41 | 2019-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System |
| Penumbra, INC. | $22,133.58 | 2019-2025 | Indigo System, Ruby Coil, Penumbra System |
| Silk Road Medical, INC. | $21,231.18 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Vesalio, INC. | $10,250.00 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $8,514.92 | 2019-2025 | Gore Viabahn Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic Vascular, INC. | $5,547.77 | 2019-2020 | |
| Aidoc Medical LTD | $4,800.00 | 2024 | Briefcase |
| Tactile Systems Technology INC | $416.36 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Philips North America LLC | $167.75 | 2024-2025 | Zenition 90, IV Other, (Dd1) Duo Hybrid |
| Shape Memory Medical INC. | $149.82 | 2024 | Impede Embolization Plug |
| Veryan Medical Incorporated | $149.61 | 2025 | Biomimics 3d Vascular Stent System |
| Shockwave Medical, INC | $133.33 | 2021 | |
| Boston Scientific Corporation | $115.94 | 2025 | General - Vascular Intervention |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $96.71 | 2021 | |
| Stryker Corporation | $73.61 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Smith+Nephew, INC. | $33.28 | 2025 | Grafix Pl |
| Novartis Pharmaceuticals Corporation | $21.35 | 2025 | |
| Bard Peripheral Vascular, INC. | $21.17 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $20.14 | 2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $19.13 | 2024 | Xarelto |
| Lemaitre Vascular, INC. | $19.10 | 2024 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naiem Nassiri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.